Akero Therapeutics
(NASDAQ:AKRO)
Akero Therapeutics, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Akero Therapeutics, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$13.30
0.65[5.14%]
At close: Aug 12
$12.65
-0.6500[-4.89%]
After Hours: 4:01PM EDT
Day High/Low12.84 - 13.47
52 Week High/Low7.52 - 22.33
Open / Close12.84 / 13.3
Float / Outstanding30.3M / 37.6M
Vol / Avg.189.6K / 379.5K
Mkt Cap499.7M
P/E-
50d Avg. Price10.71
Div / Yield-
Payout Ratio-
EPS-0.77
Total Float30.3M

Akero Therapeutics (NASDAQ:AKRO), Quotes and News Summary

Akero Therapeutics (NASDAQ: AKRO)

Day High/Low12.84 - 13.47
52 Week High/Low7.52 - 22.33
Open / Close12.84 / 13.3
Float / Outstanding30.3M / 37.6M
Vol / Avg.189.6K / 379.5K
Mkt Cap499.7M
P/E-
50d Avg. Price10.71
Div / Yield-
Payout Ratio-
EPS-0.77
Total Float30.3M
Sector: Health Care.Industry: Biotechnology
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Akero Therapeutics Questions & Answers

Q
How do I buy Akero Therapeutics (AKRO) stock?
A

You can purchase shares of Akero Therapeutics (NASDAQ: AKRO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Akero Therapeutics's (AKRO) competitors?
Q
What is the target price for Akero Therapeutics (AKRO) stock?
A

The latest price target for Akero Therapeutics (NASDAQ: AKRO) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting AKRO to fall to within 12 months (a possible -69.92% downside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Akero Therapeutics (AKRO)?
A

The stock price for Akero Therapeutics (NASDAQ: AKRO) is $13.3 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Akero Therapeutics (AKRO) pay a dividend?
A

The next Akero Therapeutics (AKRO) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Akero Therapeutics (NASDAQ:AKRO) reporting earnings?
A

Akero Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Akero Therapeutics (AKRO) going to split?
A

There is no upcoming split for Akero Therapeutics.

Q
What sector and industry does Akero Therapeutics (AKRO) operate in?
A

Akero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.